Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: Risk factors and clinical outcome

Intensive Care Medicine

Volumn 28, Issue 12, 2002, Pages 1718-1723

  Du, Bin ^a   Long, Yun ^a   Liu, Hongzhong ^a   Chen, Dechang ^a   Liu, Dawei ^a   Xu, Yingchun ^a   Xie, Xiuli ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Bacteremia; Beta lactamases; Escherichia coli; Hospital mortality; Klebsiella pneumoniae; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; IMIPENEM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DRUG EFFICACY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PATHOGENESIS; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; ANTIBIOTIC RESISTANCE; APACHE; CHI SQUARE DISTRIBUTION; CROSS INFECTION; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; APACHE; BACTEREMIA; BETA-LACTAMASES; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0036449283     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1521-1     Document Type: Article

References (14)

1. Pitout JDD, Sanders C, Snaders WE Jr (1997) Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 103:51-59
2. Knothe H, Shah P, Kremery V, et al (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317
3. Brun-Buisson C, Legrand P, Phillippon A, et al (1987) Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 2:302-306
4. Rahal JJ, Urban C, Horn D, Freeman K, et al (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233-1237
5. National nosocomial infection surveillance (NNIS) system report (1999) Data summary from January 1990-May 1999, issued June 1999. AJIC Am J Infect Control 27:520-532
6. Lautenbach E, Patel JB, Bilker WB, et al (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162-1171
7. Schiappa DA, Hayden MK, Matushek MG, et al (1996) Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation. J Infect Dis 174:529-536
8. Knaus WA, Draper EA, Wagner DP, et al (1985) APACHE II: A severity of disease classification system. Crit Care Med 13:818-829
9. Kreger BE, Craven DE, Carling PC, et al (1980) Gram-negative bacteremia: III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 68:332-343
10. National Committee for Clinical Laboratory Standards (1993) Performance standards for antimicrobial disk susceptibility tests: Approved standard. NCCLS Document M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Penn. USA
11. Jarlier V, Nicolas MH, Fournier G, et al (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867-878
12. Chow JW, Fine MJ, Shlaes DM, et al (1991) Enterbacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115:585-590
13. Landman D, Chockalingam M, Quale J (1999) Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 28:1062-1066
14. Paterson DL, Ko WC, Mohapatra S, et al (1997) Klebsiella pneumoniae bacteremia: Impact of extended spectrum beta-lactamase (ESBL) production in a global study of 216 patients. [Abstract #J-210]. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sept 28-Oct 1, 1997, Toronto, Ontario, Canada